Abstract
Objectives: Emerging evidence suggests that erythropoietin (EPO) protects the heart from ischemic injury and promotes beneficial remodelling. The role of EPO and its receptor (EPO-R) in cardiac regeneration remains unclear. We aimed to investigate cardio-protective effects and stem cell homing, proliferation and angiogenesis modulated by EPO.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
